MITO - Stealth BioTherapeutics Corp - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

MITO is currently covered by 1 analysts with an average price target of $12.08. This is a potential upside of $12.08 (0%) from yesterday's end of day stock price of $0.

Stealth BioTherapeutics Corp's activity chart (see below) currently has 6 price targets and 7 ratings on display. The stock rating distribution of MITO is 100% BUY.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 23-May-2022. First documented stock forecast 12-Mar-2019.

Best performing analysts who are covering MITO - Stealth BioTherapeutics Corp:

Matthew Luchini Christopher Marai Yi Chen

Currently out of the existing stock ratings of MITO, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

1 years 10 months 30 days ago

0/1 (0%)

$0.55 (12.36%)

Buy

28

4 years 19 days ago

0/3 (0%)

$20.85 (291.61%)

Buy

29

$28.68 (8962.50%)

5 years 1 months 10 days ago

0/1 (0%)

$14.85 (104.95%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MITO (Stealth BioTherapeutics Corp) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on MITO (Stealth BioTherapeutics Corp) with a proven track record?

MATTHEW LUCHINI

Which analyst has the current lower performing score on MITO (Stealth BioTherapeutics Corp) with a proven track record?

YI CHEN

Which analyst has the most public recommendations on MITO (Stealth BioTherapeutics Corp)?

Matthew Luchini works at BMO and has 4 price targets and 4 ratings on MITO

Which analyst is the currently most bullish on MITO (Stealth BioTherapeutics Corp)?

Matthew Luchini with highest potential upside - $28.68

Which analyst is the currently most reserved on MITO (Stealth BioTherapeutics Corp)?

Christopher Marai with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?